Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4585 On Other Exchanges
Symbol
Exchange
4585 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Fumihisa Nakata

Director of R&D, Manager of Clinical Research Development and Director, UMN Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 1 different industries.

See Board Relationships
46--

Background*

Mr. Fumihisa Nakata serves as a Director of R&D and Manager of Clinical Research Development at UMN Pharma Inc. and has been its director since August 2010. Prior to joining UMN Pharma, Mr. Nakata was involved in vaccine development programs as a regulatory member at GlaxoSmithKline K.K. in Japan and succeeded in launching Cervarix (human papilloma virus vaccine) and various influenza vaccines. Previously, he worked in Preclinical and CMC departments at Nissin Flour ...

Read Full Background

Corporate Headquarters*

The Landmark Tower Yokohama
Yokohama, Kanagawa 220-8126

Japan

Phone: 81 45 263 9200
Fax: 81 45 263 9205

Board Members Memberships*

2010-Present
Director of R&D, Manager of Clinical Research Development and Director

Education*

Master's Degree
Okayama University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4585:JP ¥3,110.00 JPY -60.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UMN PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.